Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Stephanie Y. Crawford

Stephanie Y. Crawford


Executive Associate Dean for Faculty Affairs & Strategic Initiatives, College of Pharmacy
Professor, College of Pharmacy - Pharmacy Systems Outcomes and Policy
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research

Contact

Address:

Chicago, IL, 60612

Office Phone:

(312) 413-1337 (work)

Related Sites:

About Heading link

Overview:
Stephanie Y. Crawford, PhD, MPH, FAPhA, is an educator, researcher, pharmacist, and public health advocate. She is Executive Associate Dean for Faculty Affairs & Strategic Initiatives and professor in the Department of Pharmacy Systems, Outcomes and Policy at the UIC College of Pharmacy. She holds a joint appointment as professor in the Department of Medical Education, is an Honors College Fellow, and is an affiliate faculty member in the UIC Center for Pharmacoepidemiology and Pharmacoeconomic Research. She was selected as a 2021-2022 Fellow for the President’s Executive Leadership Program, University of Illinois System. Since 2015, she has chaired the United States Pharmacopeia Expert Committee on Nomenclature and Labeling, which establishes the official title of all drug products in the U.S. She was a charter member of the U.S. Food and Drug Administration Advisory Committee on Drug Safety and Risk Management (DSaRM) and has continued to serve as a consultant and ad hoc voting member for the DSaRM since 2003. In December 2020, she was appointed as a member of the Chicago Department of Public Health COVID-19 Vaccine Scientific Advisory Committee.

Research Interests:
Research interests focus on health equity, access, and disparities reduction in safe and effective medication use. This includes targeted research on rural and inner-city populations, low-income populations, underserved minority populations, and the elderly. Related scholarly interests address research and curricular assessments in serving diverse populations. Research areas include pharmacy and health systems evaluation (e.g., medication adherence, safe medication use, optimized use of technologies) and associated patient-centered medication outcomes.

Teaching and Supervision Heading link

Pharmacy&US Healthcare System (PHAR 461), 2/14/2022 – 4/29/2022
Pharmacy&US Healthcare System (PHAR 461), 2/14/2022 – 4/29/2022
Resrch MethPharm Syst Outcomes (PSOP 502), 1/10/2022 – 4/29/2022
Pharmacy&US Healthcare System (PHAR 461), 2/15/2021 – 4/30/2021
Pharmacy&US Healthcare System (PHAR 461), 2/15/2021 – 4/30/2021
Resrch MethPharm Syst Outcomes (PSOP 502), 1/11/2021 – 4/30/2021
Pharmacy&US Healthcare System (PHAR 461), 8/24/2020 – 12/4/2020
Pharmacy&US Healthcare System (PHAR 461), 2/17/2020 – 5/1/2020
Pharmacy&US Healthcare System (PHAR 461), 2/17/2020 – 5/1/2020

Selected Grants

Addressing barriers to racial health equity in the pharmacy profession, American Association of Colleges of Pharmacy., 11/1/2021 - 9/30/2022, Obligated Amount: $22500; Anticipated Amount: $22500

Medication Safety Systems in the Community: the Role of Pharmacists White Paper, Gordon & Betty Moore Foundation., 6/1/2017 - 12/31/2017, Obligated Amount: $77130; Anticipated Amount: $77130

University of Illinois at Chicago Center of Excellence for Comparative Effectiveness Research Education, PhRMA Foundation., 1/2015 - 12/2017, Obligated Amount: $250000; Anticipated Amount: $250000

National Assessment of State Oversight of Drug Compounding, Pew Charitable Trusts., 10/1/2014 - 6/30/2016, Obligated Amount: $137013; Anticipated Amount: $137013

Mobilizing for Patients Adherence to Cancer Therapies (mPACT), McKesson Fdn., 4/7/2014 - 9/30/2017, Obligated Amount: $250000; Anticipated Amount: $250000

Mobilizing for Patient Adherence to Cancer Therapies (mPACT)., McKesson Foundation, Mobilizing for Health, 06-30-2013.., 4/1/2014 - 9/30/2017, Obligated Amount: $250000; No Anticipated Amount Set

CBA Raising the Research Profile Award, UIC College of Business Administration., 8/2011 - 6/2014, Obligated Amount: $500000; Anticipated Amount: $500000

PQA Phase II Demonstration Project: Evaluation Of Modalities for Delivering Medication Therapy Management Services, Pharmacy Quality Alliance (PQA)., 4/1/2011 - 12/31/2013, Obligated Amount: $310000; Anticipated Amount: $310000

Attitudes on the Brazilian National STD/AIDS Program under the TRIPS Agreement, Merck & Co Inc., 1/1/2006 - 6/30/2008, Obligated Amount: $40000; Anticipated Amount: $40000

Selected Publications

Paramithiotis, E, Sugden, S, Papp, E, Bonhomme, M, Chermak, T, Crawford, SY, Demetriades, SZ, Galdos, G, Lambert, BL, Mattison, J, McDade, T, Pillet, S, Murphy, R. (2022). Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.880784.

Stubbings, JA, Crawford, SY, Menighan, TE. (2022). A safe in-home disposal system with every opioid prescription? Food and Drug Administration is considering a potential new Risk Evaluation and Mitigation Strategy that could impact pharmacists. Journal of the American Pharmacists Association, 62, (2), 413-418. doi:10.1016/j.japh.2021.11.009.

Nakata, C, Sharp, LK, Spanjol, J, Cui, AS, Izberk-Bilgin, E, Crawford, SY, Xiao, Y. (2021). Narrative arcs and shaping influences in long-term medication adherence. Social Science and Medicine, 285. doi:10.1016/j.socscimed.2021.114264.

Okorie-Awé, C, Crawford, SY, Sharp, LK, Jaki, BU, Kachlic, MD. (2021). A faculty and staff workshop on microaggression and implicit bias: Knowledge and awareness of student, faculty, and staff experiences. Currents in Pharmacy Teaching and Learning, 13, (9), 1200-1209. doi:10.1016/j.cptl.2021.06.031.

Saffore, CD, Pickard, AS, Crawford, SY, Fischer, MA, Sharp, LK, Pointer, S, Lee, TA. (2021). Secondary effects of an opioid-focused academic detailing program on non-opioid controlled substance prescribing in primary care. Substance Abuse, 42, (4), 962-967. doi:10.1080/08897077.2021.1900989.

Lee, Inyoung, Jokinen, Jeremy D, Crawford, Stephanie Y, Calip, Gregory S, Kilpatrick, Ryan D, Lee, Todd A. (2021). Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.. Ther Innov Regul Sci, 55, (1), 142-151. doi:10.1007/s43441-020-00199-z.

Saffore, CD, Pickard, AS, Crawford, SY, Fischer, MA, Sharp, LK, Lee, TA. (2020). Practice change intentions after academic detailing align with subsequent opioid prescribing. Journal of the American Pharmacists Association, 60, (6), 1001-1008. doi:10.1016/j.japh.2020.08.011.

Saffore, CD, Tilton, ST, Crawford, SY, Fischer, MA, Lee, TA, Pickard, AS, Sharp, LK. (2020). Identification of barriers to safe opioid prescribing in primary care: A qualitative analysis of field notes collected through academic detailing. British Journal of General Practice, 70, (697), E589-E597. doi:10.3399/bjgp20X711737.

Lee, I, Lee, TA, Crawford, SY, Kilpatrick, RD, Calip, GS, Jokinen, JD. (2020). Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance. Expert Opinion on Drug Safety, 1357-1366. doi:10.1080/14740338.2020.1792883.

Professional Leadership

USP Council of the Convention, 8/17/2020 - Present

Chair - DIA Regional Advisory Council for the Americas, 8/17/2018 - 6/21/2022

Chair - USP Nomenclature and Labeling Expert Committee, United States Pharmacopeia, 7/1/2015 - Present

USP Council of Experts (Council oversees scientific and standards-setting decisions for medicines, excipients, and dietary supplements), United States Pharmacopeia, 2015 - Present

USP Convention representing UIC College of Pharmacy, United States Pharmacopeia, 2015 - Present

Notable Honors

2022, DIA Americas Inspire Award - Excellence in Service, DIA (founded as Drug Information Association)

2022, Honorary Co-Chair, DIA Global Annual Meeting, DIA

2021, Fellow, American Pharmacists Association (FAPhA), APhA Academy of Pharmaceutical Research & Science

2019, Rufus A. Lyman Award, American Association of Colleges of Pharmacy

2019, P1 Professor of the Semester,

2018, United States Pharmacopeia FY2017 Group Award for Outstanding Contribution to the Standards,

2018, Distinguished Honoree, UIC Urban Health Program

2017, Inaugural Best Poster Award, American Association of Colleges of Pharmacy

2017, Faculty Trailblazer Award, UIC Chancellor’s Committee on the Status of Blacks,

Education

Degrees:
B.S., University of North Carolina at Chapel Hill, United States
M.S., University of Maryland, Baltimore, United States
Ph.D., University of Texas at Austin, United States
M.P.H., University of Illinois at Chicago, United States

Postgraduate Training:
Residency in Hospital Pharmacy (ASHP accredited two-year program), University of Maryland Medical System, United States
Executive Certificate, Strategic Diversity & Inclusion Management (six-month program; 144 in-person contact hours), Georgetown University, United States